Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2024

Oct 18, 2024

3535_rns_2024-10-18_85c3439d-2072-4ee4-bd06-f2738488f657.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA - Key information relating to the Subsequent Offering

Aqua Bio Technology ASA - Key information relating to the Subsequent Offering

18.10.2024 08:53:02 CEST | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

Reference is made to the announcement by Aqua Bio Technology ASA on 18 October

2024 concerning the successful placement of the conditional private placement

with total gross proceeds of approximately NOK 115 million, and a contemplated

subsequent offering (the "Subsequent Offering").

Key information for the Subsequent Offering is set out below:

Date on which the terms of the Subsequent 17 October 2024

Offering was announced:

Last day including right: 17 October 2024

First day excluding right: 18 October 2024

Record date: 21 October 2024

EGM date: On or about 12 November 2024 (to be summoned)

Maximum number of new shares: 2,000,000

Subscription price: NOK 3.00

Shall the rights be listed No

The issuance of new shares in the Subsequent Offering will be subject to

approval of the pertaining share capital increase by the EGM to be held on or

about 12 November 2024. The Subsequent Offering is expected to be carried out

during the notice period for the EGM, with a one-week subscription period,

expected to expire at least three days prior to the date of the EGM.

This information is published in accordance with the requirements of the

Continuing Obligations in Euronext Rule Book II.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Jan Aas Varming, CFO, Aqua Bio Technology ASA, +47 908 39 076,

[email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18286102/5129/Download%20announce

ment%20as%20PDF.pdf